Deuremidevir

DB26606InvestigationalSmall molecule

Deuremidevir is a small molecule drug. Deuremidevir is under investigation in clinical trial NCT06328400 (A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension).

Mechanism: Pharmacologically active on Replicase polyprotein 1ab
Curator reviewed
Also known as: Mindeudesivir
Code names: JT-001 · VV116

Resolves to

Compound

UNIIMF2PS6XPS4CAS2647442-33-7

Targets

P0DTD1rep

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

15Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Deuremidevir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account